Cargando…

Activation of astrocytes in hippocampus decreases fear memory through adenosine A(1) receptors

Astrocytes respond to and regulate neuronal activity, yet their role in mammalian behavior remains incompletely understood. Especially unclear is whether, and if so how, astrocyte activity regulates contextual fear memory, the dysregulation of which leads to pathological fear-related disorders. We g...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yulan, Li, Lixuan, Wu, Jintao, Zhu, Zhenggang, Feng, Xiang, Qin, Liming, Zhu, Yuwei, Sun, Li, Liu, Yijun, Qiu, Zilong, Duan, Shumin, Yu, Yan-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505657/
https://www.ncbi.nlm.nih.gov/pubmed/32869747
http://dx.doi.org/10.7554/eLife.57155
Descripción
Sumario:Astrocytes respond to and regulate neuronal activity, yet their role in mammalian behavior remains incompletely understood. Especially unclear is whether, and if so how, astrocyte activity regulates contextual fear memory, the dysregulation of which leads to pathological fear-related disorders. We generated GFAP-ChR2-EYFP rats to allow the specific activation of astrocytes in vivo by optogenetics. We found that after memory acquisition within a temporal window, astrocyte activation disrupted memory consolidation and persistently decreased contextual but not cued fear memory accompanied by reduced fear-related anxiety behavior. In vivo microdialysis experiments showed astrocyte photoactivation increased extracellular ATP and adenosine concentrations. Intracerebral blockade of adenosine A(1) receptors (A(1)Rs) reversed the attenuation of fear memory. Furthermore, intracerebral or intraperitoneal injection of A(1)R agonist mimicked the effects of astrocyte activation. Therefore, our findings provide a deeper understanding of the astrocyte-mediated regulation of fear memory and suggest a new and important therapeutic strategy against pathological fear-related disorders.